NHS England turns for policy advice to group funded by drug companiesBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g1524 (Published 12 February 2014) Cite this as: BMJ 2014;348:g1524
- Gareth Iacobucci
A lobbying company with links to a string of leading pharmaceutical and medical device firms was commissioned to write a draft report for the NHS that could help guide future health policy, it has emerged.
NHS England commissioned the Specialised Healthcare Alliance to consult with patients’ groups and voluntary and healthcare organisations to produce a report to feed into its five year strategy for commissioning a range of specialist services, the Independent newspaper reported.1
The alliance describes itself as a coalition of almost 100 patient related organisations, but it is funded entirely by …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial